Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — In this video, Paul Kwo, MD, professor of medicine at Stanford University, discusses a plenary ...

Please provide your email address to receive an email when new articles are posted on . MMF demonstrated comparable safety and greater reductions in AST and ALT vs. azathioprine in autoimmune ...

Autoimmune hepatitis (AIH) is a chronic, progressive liver disease caused by immune system dysregulation that targets the liver. If untreated, AIH can lead to severe complications, including cirrhosis ...

The principle of therapy for chronic inflammatory liver diseases is the removal of causal agents. For autoimmune liver diseases, however, total removal of causal agents and immune cells is impossible.

Autoimmune hepatitis (AIH) is a complex, chronic inflammatory liver disorder in which the body's immune system aberrantly targets hepatocytes, leading to progressive hepatic injury. Characterised by ...

Autoimmune hepatitis quietly damages the liver for years before symptoms appear; specialists in Kenya warn of late diagnoses and urge early medical checks. [File, Standard] When people think about ...

Autoimmune liver diseases (ALDs), including autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC), are complex conditions involving the liver's immune ...

Several studies on rAIH were recently reviewed. [58] Because of inconsistencies in diagnostic criteria and difficulties in interpreting the nonspecific histological findings, the diagnosis can be ...

Cholestatic liver diseases and autoimmune hepatitis represent complex, immune‐mediated conditions that culminate in progressive hepatic injury. Disorders such as primary sclerosing cholangitis, ...

Scientists at the Garvan Institute of Medical Research have discovered how a viral infection causes autoimmune disease, disproving a long-standing theory and opening a promising new approach to ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in ...

Good day, everyone. My name is Mitchell, and I will be your conference operator today. At this time, I would like to welcome you to Kezar Life Sciences 2025 Topline Data Presentation of the PORTOLA ...